|
OMIM |
Link |
Information gain |
01 |
|
IDDM
|
[NCBI]
|
0.00838567
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.00413715
|
|
|
EIG1
|
[NCBI]
|
0.00170136
|
|
|
psoriasis susceptibility 9
|
[NCBI]
|
0.00170136
|
|
|
SCZD3
|
[NCBI]
|
0.001615347
|
|
|
PSORS2
|
[NCBI]
|
0.001549893
|
|
|
PEE1
|
[NCBI]
|
0.001527024
|
|
|
ST8
|
[NCBI]
|
0.001387236
|
|
|
acute myelogenous leukemia
|
[NCBI]
|
0.001220829
|
|
|
IBD7
|
[NCBI]
|
0.001220829
|
|
|
familial wilms tumor 2
|
[NCBI]
|
0.001220829
|
|
|
myopia 14
|
[NCBI]
|
0.001220829
|
|
|
MAFD1
|
[NCBI]
|
0.001217073
|
|
|
testicular germ cell tumor 1
|
[NCBI]
|
0.001139628
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
0.001122305
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
0.001122305
|
|
|
mutagen sensitivity
|
[NCBI]
|
0.001041104
|
|
|
myopia 6
|
[NCBI]
|
0.001041104
|
|
|
SHFLD2
|
[NCBI]
|
0.001041104
|
|
|
RA
|
[NCBI]
|
0.000939958
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.000925318
|
|
|
BRCA3
|
[NCBI]
|
0.000925318
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.000925318
|
|
|
otitis media, susceptibility to
|
[NCBI]
|
0.000925318
|
|
|
WT3
|
[NCBI]
|
0.000839899
|
|
|
AD13
|
[NCBI]
|
0.000839899
|
|
|
AD14
|
[NCBI]
|
0.000839899
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
0.000839899
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
0.000839899
|
|
|
MHS1
|
[NCBI]
|
0.000819513
|
|
|
SCZD6
|
[NCBI]
|
0.000693672
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
0.000690558
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.000669337
|
|
|
AUTS6
|
[NCBI]
|
0.000656371
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.0006507
|
|
|
SCZD7
|
[NCBI]
|
0.000646941
|
|
|
APS2
|
[NCBI]
|
0.000632177
|
|
|
MBP
|
[NCBI]
|
0.000632109
|
|
|
PARK3
|
[NCBI]
|
0.000592146
|
|
|
SHFLD1
|
[NCBI]
|
0.000564219
|
|
|
IDDM4
|
[NCBI]
|
0.000516424
|
|
|
MBL2
|
[NCBI]
|
0.000482937
|
|
|
MS
|
[NCBI]
|
0.000475531
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.000470014
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000448497
|
|
|
IGAD1
|
[NCBI]
|
0.000392266
|
|
|
PSORS1
|
[NCBI]
|
0.000376256
|
|
|
SCZD1
|
[NCBI]
|
0.000322335
|
|
|
epstein-barr virus, susceptibility to chronic infection by
|
[NCBI]
|
0.000307398
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.00027165
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
0.000266795
|
|
|
CPI
|
[NCBI]
|
0.000261177
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
0.000246497
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
0.000228705
|
|
|
HLA-DQA1
|
[NCBI]
|
0.0002182297
|
|
|
VEGF
|
[NCBI]
|
0.0002174437
|
|
|
SLEB1
|
[NCBI]
|
0.0002145674
|
|
|
SPDA1
|
[NCBI]
|
0.0002094447
|
|
|
HLA-DPB1
|
[NCBI]
|
0.0002085004
|
|
|
TLR4
|
[NCBI]
|
0.0001967348
|
|
|
ovarian germ cell cancer
|
[NCBI]
|
0.000188162
|
|
|
leishmaniasis, tegumentary
|
[NCBI]
|
0.000188162
|
|
|
PVR
|
[NCBI]
|
0.0001860973
|
|
|
EGF
|
[NCBI]
|
0.0001836776
|
|
|
SCZD4
|
[NCBI]
|
0.0001761679
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
0.0001678801
|
|
|
autoimmune disease
|
[NCBI]
|
0.0001673218
|
|
|
BPH
|
[NCBI]
|
0.0001657697
|
|
|
IRDN
|
[NCBI]
|
0.0001612811
|
|
|
CD
|
[NCBI]
|
0.0001582359
|
|
|
HPC1
|
[NCBI]
|
0.0001562644
|
|
|
SLC11A1
|
[NCBI]
|
0.0001553916
|
|
|
TRIM5
|
[NCBI]
|
0.0001464581
|
|
|
MPO
|
[NCBI]
|
0.000140738
|
|
|
CDKN2A
|
[NCBI]
|
0.0001394103
|
|
|
HLA-DQB1
|
[NCBI]
|
0.0001389552
|
|
|
CXCR4
|
[NCBI]
|
0.0001383538
|
|
|
malignant hyperthermia, susceptibility to, 5
|
[NCBI]
|
0.000138119
|
|
|
MAFD6
|
[NCBI]
|
0.0001369919
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.0001309479
|
|
|
RYR1
|
[NCBI]
|
0.0001298407
|
|
|
hypoproteinemia, hypercatabolic
|
[NCBI]
|
0.0001297172
|
|
|
CVID
|
[NCBI]
|
0.0001282297
|
|
|
IRGM
|
[NCBI]
|
0.0001253532
|
|
|
FY
|
[NCBI]
|
0.0001251716
|
|
|
RB1
|
[NCBI]
|
0.0001241324
|
|
|
lynch syndrome i
|
[NCBI]
|
0.0001231939
|
|
|
autism
|
[NCBI]
|
0.0001223511
|
|
|
EIG
|
[NCBI]
|
0.0001195948
|
|
|
TNF
|
[NCBI]
|
0.0001155662
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
0.0001150379
|
|
|
bilirubin, elevated concentrations of, in serum
|
[NCBI]
|
0.000112672
|
|
|
FCHL
|
[NCBI]
|
0.0001103761
|
|
|
OFC1
|
[NCBI]
|
0.0001084573
|
|
|
APOE
|
[NCBI]
|
0.0001055025
|
|
|
CMM3
|
[NCBI]
|
0.0001032284
|
|
|
XLP1
|
[NCBI]
|
0.000102734
|
|
|
macrocephaly, benign familial
|
[NCBI]
|
0.0001023046
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
0.0001008934
|
|
|
BLMH
|
[NCBI]
|
9.98508e-05
|
|
|
CEACAM5
|
[NCBI]
|
9.72115e-05
|
|
|
CMM
|
[NCBI]
|
9.43322e-05
|
|
|
KLC3
|
[NCBI]
|
9.26782e-05
|
|
|
P2RY5
|
[NCBI]
|
9.26782e-05
|
|
|
CCR5
|
[NCBI]
|
9.1962e-05
|
|
|
body mass index
|
[NCBI]
|
9.11458e-05
|
|
|
PCNA
|
[NCBI]
|
8.95718e-05
|
|
|
EHBA
|
[NCBI]
|
8.85599e-05
|
|
|
ADCC
|
[NCBI]
|
8.85599e-05
|
|
|
hyperalphalipoproteinemia
|
[NCBI]
|
8.63165e-05
|
|
|
IRF1
|
[NCBI]
|
8.61214e-05
|
|
|
EJM1
|
[NCBI]
|
8.5328e-05
|
|
|
shprintzen-goldberg craniosynostosis syndrome
|
[NCBI]
|
8.50086e-05
|
|
|
halothane hepatitis
|
[NCBI]
|
8.30846e-05
|
|
|
CYP3A4
|
[NCBI]
|
8.2269e-05
|
|
|
GRIA2
|
[NCBI]
|
8.19725e-05
|
|
|
SYN3
|
[NCBI]
|
8.13429e-05
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
8.11333e-05
|
|
|
HLA-DRA
|
[NCBI]
|
8.0861e-05
|
|
|
colorectal adenomatous polyposis, autosomal recessive
|
[NCBI]
|
8.03355e-05
|
|
|
IDD
|
[NCBI]
|
8.03355e-05
|
|
|
MG
|
[NCBI]
|
7.77376e-05
|
|
|
MSH5
|
[NCBI]
|
7.6658e-05
|
|
|
NIDDM1
|
[NCBI]
|
7.59961e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
7.58395e-05
|
|
|
GCK
|
[NCBI]
|
7.50702e-05
|
|
|
SLE
|
[NCBI]
|
7.42033e-05
|
|
|
PLD1
|
[NCBI]
|
7.41013e-05
|
|
|
SCZD2
|
[NCBI]
|
7.39555e-05
|
|
|
DISC2
|
[NCBI]
|
7.06978e-05
|
|
|
myeloid leukemia-related gene
|
[NCBI]
|
7.06978e-05
|
|
|
C6ORF27
|
[NCBI]
|
7.06978e-05
|
|
|
FCGR3B
|
[NCBI]
|
7.06978e-05
|
|
|
NIDDM
|
[NCBI]
|
6.93278e-05
|
|
|
EPHX1
|
[NCBI]
|
6.88349e-05
|
|
|
PRNP
|
[NCBI]
|
6.68053e-05
|
|
|
AFP
|
[NCBI]
|
6.55404e-05
|
|
|
CJD
|
[NCBI]
|
6.50984e-05
|
|
|
BRCA1
|
[NCBI]
|
6.44176e-05
|
|
|
PRKCQ
|
[NCBI]
|
6.40979e-05
|
|
|
ESPL1
|
[NCBI]
|
6.40979e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
6.37718e-05
|
|
|
SCN2B
|
[NCBI]
|
6.29126e-05
|
|
|
CCBP2
|
[NCBI]
|
6.29126e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
6.19568e-05
|
|
|
PI6
|
[NCBI]
|
6.19291e-05
|
|
|
APOL1
|
[NCBI]
|
6.19291e-05
|
|
|
FANCA
|
[NCBI]
|
6.1808e-05
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
6.15435e-05
|
|
|
MODY1
|
[NCBI]
|
6.13993e-05
|
|
|
CSNK2B
|
[NCBI]
|
6.10889e-05
|
|
|
E2F4
|
[NCBI]
|
6.10889e-05
|
|
|
IFNGR2
|
[NCBI]
|
6.10889e-05
|
|
|
ARMD4
|
[NCBI]
|
6.02314e-05
|
|
|
SLC5A6
|
[NCBI]
|
5.97062e-05
|
|
|
NDUFV2
|
[NCBI]
|
5.89318e-05
|
|
|
BRCA2
|
[NCBI]
|
5.77745e-05
|
|
|
CASP12
|
[NCBI]
|
5.77465e-05
|
|
|
HLA-A
|
[NCBI]
|
5.71431e-05
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
5.68423e-05
|
|
|
breast cancer
|
[NCBI]
|
5.67687e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
5.64546e-05
|
|
|
TAS2R16
|
[NCBI]
|
5.59228e-05
|
|
|
ITGB6
|
[NCBI]
|
5.55893e-05
|
|
|
g30 gene
|
[NCBI]
|
5.55893e-05
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
5.55238e-05
|
|
|
HRH1
|
[NCBI]
|
5.51898e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
5.45084e-05
|
|
|
PON3
|
[NCBI]
|
5.4404e-05
|
|
|
CD55
|
[NCBI]
|
5.34278e-05
|
|
|
TLR10
|
[NCBI]
|
5.34205e-05
|
|
|
FANCF
|
[NCBI]
|
5.31129e-05
|
|
|
g72 gene
|
[NCBI]
|
5.19276e-05
|
|
|
SBDS
|
[NCBI]
|
5.19276e-05
|
|
|
GRIK1
|
[NCBI]
|
5.18473e-05
|
|
|
UGB
|
[NCBI]
|
5.13347e-05
|
|
|
EVPL
|
[NCBI]
|
5.01039e-05
|
|
|
SCN1
|
[NCBI]
|
5.00408e-05
|
|
|
JBS
|
[NCBI]
|
4.98232e-05
|
|
|
RP
|
[NCBI]
|
4.8836e-05
|
|
|
CYP24A1
|
[NCBI]
|
4.87212e-05
|
|
|
APOA1
|
[NCBI]
|
4.83631e-05
|
|
|
ACHE
|
[NCBI]
|
4.77401e-05
|
|
|
MATN1
|
[NCBI]
|
4.76089e-05
|
|
|
HCF2
|
[NCBI]
|
4.74046e-05
|
|
|
GPR98
|
[NCBI]
|
4.74046e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
4.6934e-05
|
|
|
ICSBP1
|
[NCBI]
|
4.67549e-05
|
|
|
ASPN
|
[NCBI]
|
4.67549e-05
|
|
|
FCGR2A
|
[NCBI]
|
4.66798e-05
|
|
|
KLK3
|
[NCBI]
|
4.658063e-05
|
|
|
S100A7
|
[NCBI]
|
4.65084e-05
|
|
|
IRF2
|
[NCBI]
|
4.57754e-05
|
|
|
DCD
|
[NCBI]
|
4.51257e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
4.49847e-05
|
|
|
ATP1A1
|
[NCBI]
|
4.47135e-05
|
|
|
C1QA
|
[NCBI]
|
4.45424e-05
|
|
|
GFAP
|
[NCBI]
|
4.41686e-05
|
|
|
alcohol dependence
|
[NCBI]
|
4.41398e-05
|
|
|
PON2
|
[NCBI]
|
4.40134e-05
|
|
|
CF
|
[NCBI]
|
4.39902e-05
|
|
|
PRDX5
|
[NCBI]
|
4.35297e-05
|
|
|
DDB2
|
[NCBI]
|
4.31753e-05
|
|
|
SKI
|
[NCBI]
|
4.30843e-05
|
|
|
FANCE
|
[NCBI]
|
4.28368e-05
|
|
|
IL12RB1
|
[NCBI]
|
4.26238e-05
|
|
|
MLH1
|
[NCBI]
|
4.23884e-05
|
|
|
ETM1
|
[NCBI]
|
4.23079e-05
|
|
|
SNCA
|
[NCBI]
|
4.20791e-05
|
|
|
ITGAV
|
[NCBI]
|
4.15904e-05
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
4.14763e-05
|
|
|
CILP
|
[NCBI]
|
4.14133e-05
|
|
|
C5R1
|
[NCBI]
|
4.04842e-05
|
|
|
BRIP1
|
[NCBI]
|
4.03418e-05
|
|
|
CSF3R
|
[NCBI]
|
4.00715e-05
|
|
|
lung cancer
|
[NCBI]
|
3.96122e-05
|
|
|
FCGR3A
|
[NCBI]
|
3.93278e-05
|
|
|
osteoarthritis
|
[NCBI]
|
3.90689e-05
|
|
|
CCKAR
|
[NCBI]
|
3.86157e-05
|
|
|
FCGR2B
|
[NCBI]
|
3.80281e-05
|
|
|
SLC1A1
|
[NCBI]
|
3.73001e-05
|
|
|
PRL
|
[NCBI]
|
3.71875e-05
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
3.71112e-05
|
|
|
APOM
|
[NCBI]
|
3.69584e-05
|
|
|
CR1
|
[NCBI]
|
3.67444e-05
|
|
|
ADH2
|
[NCBI]
|
3.64272e-05
|
|
|
CAMP
|
[NCBI]
|
3.59917e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
3.57112e-05
|
|
|
GRIN1
|
[NCBI]
|
3.56698e-05
|
|
|
SEDC
|
[NCBI]
|
3.53608e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
3.50724e-05
|
|
|
ALOX5
|
[NCBI]
|
3.49022e-05
|
|
|
MODY
|
[NCBI]
|
3.48615e-05
|
|
|
LIP
|
[NCBI]
|
3.47086e-05
|
|
|
IL9
|
[NCBI]
|
3.46761e-05
|
|
|
CD4
|
[NCBI]
|
3.43953e-05
|
|
|
CREB1
|
[NCBI]
|
3.43953e-05
|
|
|
C5
|
[NCBI]
|
3.42466e-05
|
|
|
MMP12
|
[NCBI]
|
3.3946e-05
|
|
|
HMOX1
|
[NCBI]
|
3.3946e-05
|
|
|
GRIA1
|
[NCBI]
|
3.377862e-05
|
|
|
H2AFX
|
[NCBI]
|
3.35713e-05
|
|
|
NRCLP1
|
[NCBI]
|
3.3403e-05
|
|
|
SLPI
|
[NCBI]
|
3.34012e-05
|
|
|
TNFRSF14
|
[NCBI]
|
3.3297e-05
|
|
|
MUTYH
|
[NCBI]
|
3.32707e-05
|
|
|
CYP27B1
|
[NCBI]
|
3.31324e-05
|
|
|
CACNA1S
|
[NCBI]
|
3.29858e-05
|
|
|
TCRB
|
[NCBI]
|
3.23393e-05
|
|
|
FTD
|
[NCBI]
|
3.22471e-05
|
|
|
TP53
|
[NCBI]
|
3.22432e-05
|
|
|
XRCC9
|
[NCBI]
|
3.20565e-05
|
|
|
FMF
|
[NCBI]
|
3.19111e-05
|
|
|
APC
|
[NCBI]
|
3.14762e-05
|
|
|
SAA1
|
[NCBI]
|
3.1471e-05
|
|
|
NR4A3
|
[NCBI]
|
3.12218e-05
|
|
|
TCRG
|
[NCBI]
|
3.09997e-05
|
|
|
HAMP
|
[NCBI]
|
3.0951e-05
|
|
|
ABO
|
[NCBI]
|
3.072901e-05
|
|
|
GSTM1
|
[NCBI]
|
3.06984e-05
|
|
|
GSTP1
|
[NCBI]
|
3.01203e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
2.96513e-05
|
|
|
DISC1
|
[NCBI]
|
2.9534e-05
|
|
|
HSPB1
|
[NCBI]
|
2.89842e-05
|
|
|
SOD2
|
[NCBI]
|
2.86965e-05
|
|
|
AACT
|
[NCBI]
|
2.85416e-05
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
2.84289e-05
|
|
|
PROP1
|
[NCBI]
|
2.83573e-05
|
|
|
LAD
|
[NCBI]
|
2.81789e-05
|
|
|
PI
|
[NCBI]
|
2.81181e-05
|
|
|
CMD1A
|
[NCBI]
|
2.79158e-05
|
|
|
LFS1
|
[NCBI]
|
2.78082e-05
|
|
|
DST
|
[NCBI]
|
2.77997e-05
|
|
|
CDK6
|
[NCBI]
|
2.762705e-05
|
|
|
MDD
|
[NCBI]
|
2.7426e-05
|
|
|
POAG
|
[NCBI]
|
2.72757e-05
|
|
|
IGER
|
[NCBI]
|
2.72555e-05
|
|
|
PTX3
|
[NCBI]
|
2.70788e-05
|
|
|
CYP2D6
|
[NCBI]
|
2.706781e-05
|
|
|
C4A
|
[NCBI]
|
2.667746e-05
|
|
|
COMT
|
[NCBI]
|
2.658617e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
2.65259e-05
|
|
|
WFS1
|
[NCBI]
|
2.64318e-05
|
|
|
TP73L
|
[NCBI]
|
2.58862e-05
|
|
|
HYPP
|
[NCBI]
|
2.58593e-05
|
|
|
MAP1B
|
[NCBI]
|
2.551412e-05
|
|
|
FGG
|
[NCBI]
|
2.537752e-05
|
|
|
IL12B
|
[NCBI]
|
2.5366e-05
|
|
|
CD40LG
|
[NCBI]
|
2.53445e-05
|
|
|
XPC
|
[NCBI]
|
2.51767e-05
|
|
|
SLC6A4
|
[NCBI]
|
2.511402e-05
|
|
|
CRH
|
[NCBI]
|
2.491038e-05
|
|
|
SOCS1
|
[NCBI]
|
2.459172e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
2.400385e-05
|
|
|
CSF2
|
[NCBI]
|
2.302162e-05
|
|
|
EDNRB
|
[NCBI]
|
2.265591e-05
|
|
|
LTA
|
[NCBI]
|
2.263582e-05
|
|
|
NGFB
|
[NCBI]
|
2.229328e-05
|
|
|
MMP3
|
[NCBI]
|
2.19726e-05
|
|
|
PARG
|
[NCBI]
|
2.174583e-05
|
|
|
RECQL2
|
[NCBI]
|
2.166921e-05
|
|
|
VDR
|
[NCBI]
|
2.141808e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
2.13997e-05
|
|
|
HGF
|
[NCBI]
|
2.110019e-05
|
|
|
ACE
|
[NCBI]
|
2.100241e-05
|
|
|
neuroblastoma
|
[NCBI]
|
2.061817e-05
|
|
|
F3
|
[NCBI]
|
2.017256e-05
|
|
|
TLR3
|
[NCBI]
|
1.95964e-05
|
|
|
DRD2
|
[NCBI]
|
1.9316e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
1.91514e-05
|
|
|
CEACAM1
|
[NCBI]
|
1.906801e-05
|
|
|
APCS
|
[NCBI]
|
1.892282e-05
|
|
|
ITGB2
|
[NCBI]
|
1.886836e-05
|
|
|
SLC2A2
|
[NCBI]
|
1.873821e-05
|
|
|
TG
|
[NCBI]
|
1.865383e-05
|
|
|
NPPA
|
[NCBI]
|
1.821401e-05
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
1.81951e-05
|
|
|
COL7A1
|
[NCBI]
|
1.801912e-05
|
|
|
CCK
|
[NCBI]
|
1.790835e-05
|
|
|
RCC1
|
[NCBI]
|
1.745763e-05
|
|
|
SLC11A2
|
[NCBI]
|
1.720549e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
1.715087e-05
|
|
|
HFE
|
[NCBI]
|
1.689871e-05
|
|
|
TNFSF6
|
[NCBI]
|
1.686631e-05
|
|
|
F2
|
[NCBI]
|
1.659657e-05
|
|
|
ANG
|
[NCBI]
|
1.649609e-05
|
|
|
MMP2
|
[NCBI]
|
1.644852e-05
|
|
|
MSH2
|
[NCBI]
|
1.627545e-05
|
|
|
G6PD
|
[NCBI]
|
1.620843e-05
|
|
|
EPO
|
[NCBI]
|
1.605563e-05
|
|
|
B2M
|
[NCBI]
|
1.556063e-05
|
|
|
WT1
|
[NCBI]
|
1.528328e-05
|
|
|
GC
|
[NCBI]
|
1.511531e-05
|
|
|
CFTR
|
[NCBI]
|
1.501704e-05
|
|
|
TGFB1
|
[NCBI]
|
1.488866e-05
|
|
|
LQT1
|
[NCBI]
|
1.476369e-05
|
|
|
ESD
|
[NCBI]
|
1.457089e-05
|
|
|
CAT
|
[NCBI]
|
1.378515e-05
|
|
|
AT
|
[NCBI]
|
1.372096e-05
|
|
|
VIP
|
[NCBI]
|
1.365806e-05
|
|
|
hypertension, essential
|
[NCBI]
|
1.335992e-05
|
|
|
temporal arteritis
|
[NCBI]
|
1.305043e-05
|
|
|
DBI
|
[NCBI]
|
1.298164e-05
|
|
|
CHAT
|
[NCBI]
|
1.269317e-05
|
|
|
HNF1A
|
[NCBI]
|
1.238388e-05
|
|
|
MTHFR
|
[NCBI]
|
1.206457e-05
|
|
|
IDE
|
[NCBI]
|
1.191198e-05
|
|
|
TNFSF10
|
[NCBI]
|
1.185135e-05
|
|
|
LBP
|
[NCBI]
|
1.17429e-05
|
|
|
PSACH
|
[NCBI]
|
1.162692e-05
|
|
|
UCN
|
[NCBI]
|
1.123036e-05
|
|
|
IBD1
|
[NCBI]
|
1.121963e-05
|
|
|
factor v deficiency
|
[NCBI]
|
1.10837e-05
|
|
|
RNASE2
|
[NCBI]
|
1.104585e-05
|
|
|
TYMS
|
[NCBI]
|
1.08684e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
1.057991e-05
|
|
|
GTS
|
[NCBI]
|
1.055237e-05
|
|
|
PD
|
[NCBI]
|
1.011975e-05
|
|
|
ESR1
|
[NCBI]
|
1.007609e-05
|
|
|
AD
|
[NCBI]
|
9.9781e-06
|
|
|
STAT1
|
[NCBI]
|
9.96797e-06
|
|
|
CYP1A1
|
[NCBI]
|
9.52083e-06
|
|
|
WRN
|
[NCBI]
|
9.498e-06
|
|
|
MPZ
|
[NCBI]
|
9.41245e-06
|
|
|
SDS
|
[NCBI]
|
9.29856e-06
|
|
|
PPARG
|
[NCBI]
|
8.78366e-06
|
|
|
PG
|
[NCBI]
|
8.3358e-06
|
|
|
CFH
|
[NCBI]
|
7.62827e-06
|
|
|
MEN1
|
[NCBI]
|
7.47588e-06
|
|
|
NR1I2
|
[NCBI]
|
7.302403e-06
|
|
|
FBN1
|
[NCBI]
|
7.25517e-06
|
|
|
BDNF
|
[NCBI]
|
7.23596e-06
|
|
|
RHO
|
[NCBI]
|
6.98164e-06
|
|
|
NPY
|
[NCBI]
|
6.902987e-06
|
|
|
MAPT
|
[NCBI]
|
6.64904e-06
|
|
|
PON1
|
[NCBI]
|
6.55397e-06
|
|
|
AR
|
[NCBI]
|
6.52518e-06
|
|
|
CCND1
|
[NCBI]
|
6.35561e-06
|
|
|
PLTP
|
[NCBI]
|
6.1243e-06
|
|
|
APS1
|
[NCBI]
|
5.98461e-06
|
|
|
SHBG
|
[NCBI]
|
5.93243e-06
|
|
|
TH
|
[NCBI]
|
5.7337567e-06
|
|
|
MFS
|
[NCBI]
|
5.72659e-06
|
|
|
PTK2
|
[NCBI]
|
5.66226e-06
|
|
|
HBB
|
[NCBI]
|
5.33115e-06
|
|
|
BWS
|
[NCBI]
|
5.12956e-06
|
|
|
HP
|
[NCBI]
|
5.12498e-06
|
|
|
IL6
|
[NCBI]
|
5.05109e-06
|
|
|
CDK4
|
[NCBI]
|
5.04555e-06
|
|
|
LEP
|
[NCBI]
|
4.81198e-06
|
|
|
SERPINA6
|
[NCBI]
|
4.555903e-06
|
|
|
TTR
|
[NCBI]
|
4.218734e-06
|
|
|
DBA
|
[NCBI]
|
4.08316e-06
|
|
|
PSEN1
|
[NCBI]
|
4.07604e-06
|
|
|
PMCH
|
[NCBI]
|
3.814881e-06
|
|
|
AVP
|
[NCBI]
|
3.79143e-06
|
|
|
apc gene
|
[NCBI]
|
3.74053e-06
|
|
|
APOB
|
[NCBI]
|
3.66436e-06
|
|
|
BCHE
|
[NCBI]
|
3.569989e-06
|
|
|
TLR2
|
[NCBI]
|
3.51678e-06
|
|
|
VHL
|
[NCBI]
|
3.49385e-06
|
|
|
APP
|
[NCBI]
|
3.37676e-06
|
|
|
HDC
|
[NCBI]
|
3.20749e-06
|
|
|
PEDF
|
[NCBI]
|
3.1584e-06
|
|
|
APRT
|
[NCBI]
|
3.053809e-06
|
|
|
LRP1
|
[NCBI]
|
3.028807e-06
|
|
|
SPP1
|
[NCBI]
|
2.88208e-06
|
|
|
SLC6A3
|
[NCBI]
|
2.872744e-06
|
|
|
HEMB
|
[NCBI]
|
2.851768e-06
|
|
|
RNASE3
|
[NCBI]
|
2.83451743e-06
|
|
|
PTHLH
|
[NCBI]
|
2.654644e-06
|
|
|
AKR1B1
|
[NCBI]
|
2.308869e-06
|
|
|
TFPI
|
[NCBI]
|
2.10021e-06
|
|
|
WAS
|
[NCBI]
|
1.860809e-06
|
|
|
AHR
|
[NCBI]
|
1.6783702e-06
|
|
|
TF
|
[NCBI]
|
1.444073e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.4278876e-06
|
|
|
GAPDH
|
[NCBI]
|
1.292609e-06
|
|
|
PGR
|
[NCBI]
|
1.2130341e-06
|
|
|
CRC
|
[NCBI]
|
1.116016e-06
|
|
|
HPS
|
[NCBI]
|
1.033913e-06
|
|
|
ADA
|
[NCBI]
|
9.969252e-07
|
|
|
LPL
|
[NCBI]
|
9.96887e-07
|
|
|
POMC
|
[NCBI]
|
9.64619e-07
|
|
|
NF1
|
[NCBI]
|
8.74036e-07
|
|
|
FA
|
[NCBI]
|
6.740475e-07
|
|
|
CP
|
[NCBI]
|
5.97656e-07
|
|
|
BL
|
[NCBI]
|
4.890985e-07
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
4.87665e-07
|
|
|
LDLR
|
[NCBI]
|
4.79118e-07
|
|
|
CTGF
|
[NCBI]
|
3.064775e-07
|
|
|
PF4
|
[NCBI]
|
2.714950343136e-07
|
|
|
DGS
|
[NCBI]
|
1.25869e-07
|
|
|
IL2
|
[NCBI]
|
8.641091e-08
|
|
|
CHS
|
[NCBI]
|
7.0899485e-08
|
|
|
PPARA
|
[NCBI]
|
2.351339e-09
|
|